Tipos de mortes celulares induzidas pela terapia fotodinâmica com azul de metileno em células de câncer de mama murino in vitro e in vivo
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Photodynamic therapy (PDT) stands out as a minimally invasive therapeutic modality
based on the activation of a photosensitizer by light at a specific wavelength in the
presence of molecular oxygen, promoting the localized generation of reactive oxygen
species capable of inducing selective cell death. Among the available photosensitizers,
methylene blue (MB) has high availability, low cost, and favorable photophysical
properties, making it a promising alternative for the treatment of neoplasms. However,
gaps remain regarding the molecular mechanisms triggered by methylene bluemediated photodynamic therapy (MB-PDT) and the influence of dosimetric parameters
on the activation of different forms of cell death. The present study aimed to evaluate
the cell death mechanisms induced by MB-mediated PDT (MB-PDT) in in vitro and in
vivo experimental models of 4T1 murine mammary carcinoma, using two
photosensitizer concentrations (25 and 50 µM) and investigating the pathways of
apoptosis, autophagy, necroptosis, and ferroptosis. Initially, the experimental
parameters were established through cell viability assays, determining the methylene
blue concentrations and defining the photodynamic protocol. Irradiation was performed
using an InGaAlP diode laser at a wavelength of 660 nm, with a power output of 100
mW, spot area of 0.028 cm², energy of 2.8 J per point, energy density of 100 J/cm²,
irradiance of 3.57 W/cm², and exposure time of 28 s per point. Subsequently, cell
migration assays, gene expression analysis by RT-qPCR, functional assessment of cell
death pathways using specific pharmacological inhibitors, and histopathological and
immunohistochemical characterization were performed in BALB/c mice bearing 4T1
cell-induced mammary carcinoma. The results demonstrated that MB-PDT significantly
reduced tumor cell viability and migratory capacity. Gene expression analysis revealed
modulation of markers associated with regulated cell death pathways, with a greater
contribution of mechanisms related to autophagy and ferroptosis. Pharmacological
inhibitor assays confirmed the functional contribution of ferroptosis to the cytotoxicity
induced by the therapy. In the in vivo model, the treatment was shown to be safe, with
no evidence of systemic toxicity. Although no significant differences in macroscopic
tumor volume regression were observed during the experimental period, molecular and
immunohistochemical analyses revealed alterations consistent with the activation of
different immunogenic cell death pathways in the tumor tissue, including necroptosis.
MB-PDT represents a promising antitumor strategy for the treatment of experimental
mammary carcinoma, capable of inducing multiple regulated cell death pathways,
particularly autophagy, necroptosis, and ferroptosis. These findings expand the
understanding of the molecular mechanisms involved in photodynamic therapy and
provide a basis for optimizing therapeutic parameters and developing translational
protocols for breast cancer treatment.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

